Thrombotic and hemorrhagic complications of stenting coronary arteries: Incidence, management and prevention
Tóm tắt
Stents are intravascular prostheses which provide endoluminal scaffolding, effectively reducing elastic recoil and sealing local dissections. Stents have become the treatment of choice for acute vessel closure following percutaneous coronary intervention. In addition, by providing a large, smooth lumen, stenting increases procedural success and decreases late restenosis compared with conventional balloon angioplasty. All stents evaluated clinically are constructed of non-corrosive metallic alloys which are inherently thrombogenic. The incidence of stent thrombosis ranges from 0.4-18%. While acute thrombosis is uncommon, subacute thrombosis may occur from 5 to 21 days (mean 7 days) after placement. Predictors of stent thrombosis include stenting for bailout indication, angiographically visible thrombus after implantation, stenting of smaller vessels, presence of residual dissection after stenting, poor distal runoff, incomplete stent expansion and stenting in the setting of acute myocardial infarction. Stent thrombosis is associated with high incidence of Q-wave myocardial infarction (70–90%) and mortality (7–20%), and is best treated with emergency catheterization and balloon angioplasty. To prevent stent thrombosis, aggressive procedural and postprocedural pharmacological regimens employing antiplatelet agents (aspirin, dipyridamole and dextran) and anticoagulation (heparin followed by warfarin) have been used. While these regimens have reduced the incidence of stent thrombosis to <5%, they are associated with a high incidence of vascular and hemorrhagic complications, increased length of hospitalization and total cost. To decrease the incidence of stent thrombosis and obviate the need for anticoagulation, strategies such as intravascular ultrasound guided “optimal stenting” and addition of the antiplatelet agent ticlopidine, are being evaluated. In the future coating of stents with agents such as heparin, may further reduce the risk of thrombosis and the requirement for long-term anticoagulation.
Tài liệu tham khảo
Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.Engl J Med 1987;316:701–706.
Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents.J Am Coll Cardiol 1993;21:26–34.
Fischman DL, Savage MP, Leon MB, et al. Effect of intracoronary stenting on intimai dissection after balloon angioplasty: Results of quantitative and qualitative coronary analysis.J Am Coll Cardiol 1991;18:1445–1451.
Schatz RA, Penn IM, Bairn DS, et al. Stent Restenosis Study (STRESS): An analysis of in-hospital results.Circulation 1993;88:594A.
Serruys PW, Macaya C, de Jaegere P, et al. Interim analysis of the BENESTENT trial.Circulation 1993;88:594A.
DePalma VA, Baier RE, Ford JW, Gott VL, Furuse A. Investigation of three-surface properties of several metals and their relation to blood compatibility. In: Homsy C, Armeniades CD, eds.Biomaterials for Skeletal and Cardiovascular Applications. New York: John Wiley and Sons, 1972:37–45.
Krupski WC, Bass A, Kelly AB, Marzec UM, Hanson SR, Harker LA. Heparin-resistant thrombus formation by endovascular stents in baboons.Circulation 1990;81:570–577.
Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter S. Balloon-expandable intracoronary stents in the adult dog.Circulation 1987;76:450–457.
Schatz RA. A view of vascular stents.Circulation 1989;79:445–457.
Serruys PW, Strauss BH, Beatt KH, et al. Angiographic follow-up after placement of a self-expanding coronary artery stent.N Engl J Med 1991;324:13–17.
Carrozza JP, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience.J Am Coll Cardiol 1992;20:328–337.
Colombo A, Maiello L, Almagor Y, et al. Coronary stenting: Single institution experience with the initial 100 cases using the Palmaz-Schatz stent.Cathet Cardiovasc Diag 1992;26:171–176.
George BS, Voorhees WD III, Roubin GS, et al. Multicenter investigation of coronary stenting to acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes.J Am Coll Cardiol 1993;22:135–143.
Haude M, Erbel R, Straub U, Dietz U, Meyer J. Short and long term results after intracoronary stenting in human coronary arteries: Monocentre experience with the balloon-expandable Palmaz-Schatz stent.Br Heart J 1991;66:337–345.
Wong PHC, Wong CM, Ko PTH, et al. Two years experience with the Palmaz-Schatz coronary stent in a heterogeneous patient population.J Invas Cardiol 1993;5:267–276.
Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study.Circulation 1991;83:148–161.
Holmes DR, Garratt KN, Schwartz RS, White C. Timing of stent occlusion/thrombosis after stent placement.J Am Coll Cardiol 1994;70A.
Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease.N Engl J Med 1994;331:489.
Serruys PW, Heyndrickx G, Emanuelsson H, et al. Interim analysis of the BENESTENT trial.Circulation 1993;88:594A.
Schatz RA, Goldberg S, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent.J Am Coll Cardiol 1991;17:155–159B.
Capers Q, Thomas CN, Weintraub WS, King SB III, Douglas JS Jr, Scott NA. Emergent stent placement: Worse outcome in patients with a recent myocardial infarction.J Am Coll Cardiol 1994;71A.
Nath FC, Muller DWM, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome.J Am Coll Cardiol 1993;21:622–627.
Baim DS, Levine MJ, Leon MB, Levine S, Ellis SG, Schatz RA. Management of restenosis within the Palmaz-Schatz coronary stent (The U.S. Multicenter Experience).Am J Cardiol 1993;71:364–366.
Hermann HC, Buchbinder M, Clemen MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.Circulation 1992;86:812–819.
Doucet S, Fajadet J, Caillard J, Cassagneau B, Robert G, Marco J. Predictors of thrombotic occlusions following coronary Palmaz-Schatz stent implantation.Circulation 1992;86:113A.
Agrawal S, Hearn JA, Liu MW, et al. Stent thrombosis and ischemic complications following coronary artery stenting.Circulation 1992;86:113A.
Fischman DL, Savage MP, Leon MB. Angiographie predictors of subacute thrombosis during coronary artery stenting.Circulation 1991;84:588A.
Triana JF, Vorhees WD, Fearnot NE, George B, Kleiman NS, Raizner AE. Intracoronary stent thrombosis: A major contributor to an adverse long term outcome.Circulation 1993;86:113A.
Rocha-Singh K, Shaknovich A, Wong SC, Teirstein PS. Management of subacute stent thrombosis.Circulation 1993;86:114A.
Brown DL, Brener SJ, Rios GD, Kottke-Marchant K. Thrombin activity and platelet activation following cessation of heparin in patients after intracoronary stenting.J Am Coll Cardiol 1994;336A.
Moscucci M, Mansour KA, Kent KG, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management and outcome.Am J Cardiol 1994;74:448.
Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.Circulation 1995;91:1676–1688.
Barragan PT, Silvestri MA, Sainsous JB, Bouvier JL, Comet BL, Siméoni JB. Coronary stenting without coumadin.J Am Coll Cardiol 1994;336A.
Morice M. Advances in post stenting medication protocol.Journal of Invasive Cardiology 1995;7:32A-35A.
Dichek DA, Neville RF, Zweibel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered cells.Circulation 1989;80:1347–1353.
Nordrehaug JE, Chronos N, Sigwart U. A biocompatible phosphotidylcholine coating applied to metallic stents.J Am Coll Cardiol 1994;5A.
van Beusekom HMM, van der Giessen WJ, Schenau DV, Slager CJ. Synthetic polymers as an alternative to metal in stents? In vivo and mechanical behavior of polyethyleneterephtalate.Circulation 1992;86:731A.
Mahrer KN, Eigler NL, Khorsandi MJ, et al. Development of the heat activated recoverable temporary stent (HARTS) with a slotted tube design for coronary application.J Am Coll Cardiol 1994;103A.